FDA wants guidance on guidances WASHINGTON - FDA published a list of guidance documents that its Center for Biologics Evaluation and Research (CBER), Center for Drugs Evaluation and Research (CDER) and other centers plan to issue during the next year. The agency also solicited additional ideas for new topics or revisions to existing guidance documents (see Online Links, A12).